Baxter has been honored to be recognized globally with various awards and distinctions by the industry, as well as by sustainability, community support and environmental organizations. Download the attached for a sampling, with a full list available at baxter.com
Literature / Brochures
Awards
More Literature / Brochures by Baxter BioPharma Solutions
-
Brochures
Capabilities Brochure - The Promise of Science Max
Maximize your molecule's full potential. Formulation challenges. Clinical supply hurdles. Limited manufacturing capability or capacity. Market fluctuations and demand surges. Lifecycle management. Risk mitigation. Patent expiry concerns.…07.06.18
-
Brochures
Baxter Facility - Halle/Westfalen, Germany
Complex Sterile Manufacturing with More Than 60 Years of Oncology Experience…07.03.18
-
Brochures
The Promise of Science: Baxter’s Lyophilization
Experience Makes the Difference Optimizing lyophilization cycle times and improving stability for complex injectables is a critical component of parenteral product development. With this understanding, BioPharma Solutions established the Lyophiliz…07.01.18
-
Brochures
-
Brochures
Bloomington, Indiana, USA Facility Facts/Capabilit
A Global Leader in Sterile Contract Manufacturing06.23.18
-
Brochures
Halle/Westfalen, Germany Facility Facts/Capabiliti
Complex Sterile Manufacturing with More Than 60 Years of Oncology Experience01.30.17
More Content From Baxter BioPharma Solutions
-
Leak Rate Testing for Freeze Dryers: A Scientific Approach
Assurance of the vacuum integrity of freeze - dryers used for the manufacture of sterile pharmaceutical products is essential for GMP operations; however, there is currently no generally accepted scientific rationale for establishing acceptance crite…White Papers / Tech Papers Released on 03.08.2019
-
Pharmaceutical Development for ADCs: Not as Simple as ABC
Formulation, process, and analytical development for antibody - drug conjugates, or ADCs, is complex. While the development of an aqueous solution formulation may be preferred over a lyophilized product, it is useful to initially pursue a dual path a…White Papers / Tech Papers Released on 03.08.2019
-
Enhanced Delivery Options for Injectables
Download the Enhanced Delivery Options Poster.Posters Released on 03.08.2019
-
BIOSIMILARS: Global Terminology, Strategy & Pathways
Download the Global Terminology, Strategy & Pathways PosterPosters Released on 03.08.2019
-
Considerations for Development of Lyophilized Biosimilar
This whitepaper discusses considerations for development of a lyophilized biosimilar, as well as a biosimilar case study.White Papers / Tech Papers Released on 11.01.2018
-
Your CMO for Sterile Injectables
85+ years of expertise in process and formulation development, technology transfer, and parenteral manufacturing.Videos Released on 10.19.2018
-
Baxter's BioPharma Solutions Business Recognized with ViE Award for Fifth Time
Baxter’s BioPharma Solutions facility in Bloomington, Indiana, was recognized for the fifth time as Best Contract Manufacturing Organization at the annual Vaccine Industry Excellence (ViE) Awards, held during the 2017 World Vaccine Congress in…News Releases Released on 07.06.2018
-
Manufacturing of Cytotoxic and Non-Cytotoxic Drugs in a Multiproduct Facility
When different drug products are produced in shared facilities, the potential for cross contamination is always a concern.White Papers / Tech Papers Released on 07.06.2018
-
Process Development for Lyophilized Products
A common approach to process development for lyophilized products is to thermally characterize the solution formulation to determine the critical product temperature that should not be exceeded during primary drying. This is conducted using different…White Papers / Tech Papers Released on 07.05.2018
-
Support of Scale-Up and Technical Transfer Through Understanding Equipment for Lyophilization
Formulation and process development for injectable products are typically conducted at laboratory-scale. Laboratory-scale equipment is useful and necessary during development when there is little technical information available and especially when th…White Papers / Tech Papers Released on 07.03.2018
-
Best Practices in Formulation and Lyophilization Development: Proteins, mAbs and ADCs
The ultimate goal of formulation development is a stable product. In the case of a protein product, that can be defined as delivering the correct dose, in the native secondary and tertiary structure, without unintended chemical modifications, and fre…White Papers / Tech Papers Released on 08.01.2016
-
Baxter BioPharma Solutions Wins the 2016 ISPE Facility of the Year Awards (FOYA)
In the Operational Excellence CategoryNews Releases Released on 02.22.2016
-
Baxter Completes Capacity Expansion at Halle, Germany Facility
Supports BioPharma Solutions’ Oncology Contract Manufacturing ServicesNews Releases Released on 11.12.2015
-
Baxter BioPharma Solutions and SAFC Collaborate on Complete ADC Offering
Baxter ’s BioPharma Solutions business and SAFC have established a collaborative manufacturing agreementNews Releases Released on 09.01.2014
